Close Menu


Oregon Health and Science University will use a $41M grant to start a regional biodefense and infectious disease center.

The institute has purchased 22 new Genome Analyzers for its biomedical research programs.

The one-year program will cultivate community relations and aim to enhance knowledge about genomics and genetics research and issues.

Founded in 2000 on technology developed at the Ontario Cancer Institute and University of Toronto, Molecular Templates had difficulty securing add-on funding in its home country following a $1.5 million investment earlier this decade.

The industry standards issued last December by 23andMe, Decode, and Navigenics are "a good start, but they are really not where they need to be," said Muin Khoury, director of the CDC's Office of Public Health Genomics.

Wageningen UR will use the company's genomic sequencing technology in its efforts to map the potato's genetic code.

The company is in the late stages of closing a Series D investment, but due to the slowdown of the capital markets in recent months, "it has taken us longer than anticipated to close," a company official said.

After going through a restructuring phase at the end of last year in which it temporarily laid off its entire staff, LightSpeed continues to develop its optical detection technology and plans to test it with a new sequencing chemistry this year.

In Print


Microarray-Related Papers of Note Published in March 2009

People in the News


Frank Witney, Paul Keim, Trilochan Sahoo, Jack Lord, Mari Baker, Patrick Terry, Lutz Kirchrath


US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.